News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,661 Results
Type
Article (8019)
Company Profile (140)
Press Release (476501)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166747)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52877)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238193)
Policy (17906)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (105)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (263)
Approvals (10375)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (508)
Cancer (3647)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47867)
Collaboration (1245)
Commercialization (3)
Compensation (1468)
Complete response letters (34)
COVID-19 (755)
CRISPR (63)
C-suite (747)
Cystic fibrosis (85)
Data (5652)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (343)
Diagnostics (4188)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73715)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87612)
Executive appointments (701)
FDA (12387)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (918)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9316)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (943)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8655)
Medtech (8800)
Mergers & acquisitions (14383)
Metabolic disorders (706)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1824)
NextGen: Class of 2026 (3151)
Non-profit (841)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (507)
Peanut (31)
People (41233)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15466)
Phase 2 (21375)
Phase 3 (14400)
Pipeline (7321)
Policy (18)
Postmarket research (1570)
Preclinical (6539)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (571)
Real estate (3019)
Recruiting (6)
Regulatory (14815)
Reports (21)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (50)
Vaccines (322)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Last 7 days (219)
Last 30 days (1535)
Last 365 days (18993)
2026 (12295)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34586)
2021 (37179)
2020 (33468)
2019 (23258)
2018 (17469)
2017 (18765)
2016 (17917)
2015 (24268)
2014 (21679)
2013 (18135)
2012 (20222)
2011 (20440)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17889)
Australia (2099)
California (11965)
Canada (3147)
China (524)
Colorado (484)
Connecticut (409)
Delaware (208)
Europe (24634)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (700)
India (51)
Indiana (314)
Iowa (15)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7851)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2620)
New Mexico (12)
New York (2822)
North Carolina (1278)
North Dakota (4)
Northern California (5992)
Ohio (278)
Oklahoma (14)
Oregon (18)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4970)
Tennessee (120)
Texas (1940)
United States (38863)
Utah (360)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (928)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,661 Results for "inflammatix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inflammatix Collaborates with University of Nebraska Medical Center to Support Rapid Response to the Hantavirus Outbreak Using TriVerity®
June 17, 2026
·
4 min read
Press Releases
Inflammatix Announces Three Landmark Publications in Nature Medicine that Redefine Acute Infection and Sepsis Diagnosis and Treatment
October 1, 2025
·
8 min read
Press Releases
Inflammatix Data in Journal of Clinical Microbiology Validate Accuracy, Robustness, and Ease of Use of TriVerity™ Test System
September 3, 2025
·
5 min read
Press Releases
Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test
January 21, 2025
·
7 min read
Biotech Bay
Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System
Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the company has completed technical development for its TriVerity™ Acute Infection and Sepsis Test System, which includes the Myrna™ Instrument, and for the TriVerity™ Cartridge.
November 15, 2023
·
3 min read
FDA
Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System
Inflammatix, Inc. announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s lead product, the TriVerity™ Acute Infection and Sepsis Test System.
November 28, 2023
·
5 min read
Press Releases
Inflammatix Adds Three MedTech Industry Veterans to Executive Leadership Team
October 10, 2024
·
5 min read
Business
Inflammatix Appoints Heiner Dreismann as New Board Member
Inflammatix, a pioneering molecular diagnostics company, announced the appointment of Heiner Dreismann, PhD, as a member of the company’s board of directors.
July 10, 2023
·
2 min read
Press Releases
Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial
November 11, 2024
·
5 min read
Press Releases
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
September 12, 2024
·
6 min read
1 of 48,467
Next
